Status:
UNKNOWN
Chemerin in Colorectal Cancer and Its Relationship With Diet Quality
Lead Sponsor:
Hacettepe University
Collaborating Sponsors:
Ankara City Hospital Bilkent
Conditions:
Colorectal Cancer
Diet, Healthy
Eligibility:
All Genders
19-64 years
Brief Summary
To investigate the relationship between serum chemerin levels of individuals with colorectal cancer and systematic inflammatory response parameters such as C-reactive protein(CRP) and albumin, and to ...
Detailed Description
The research will be executed. with 52 adult individuals between the ages of 18-65 who applied to the Ankara City Hospital Oncology Hospital Medical Oncology outpatient clinic, newly diagnosed with co...
Eligibility Criteria
Inclusion
- For patient group
- Between the ages of 18-65,
- At least 3 weeks after surgery
- Individuals newly diagnosed with colorectal cancer by a oncolog (except for Stage IV)
- For healthy group
- Between the ages of 18-65,
- Healthy adult individuals without any chronic disease
Exclusion
- For patient group
- Receiving active radiotherapy or chemotherapy,
- Existing history of metastasis,
- Having a malignant disease other than the diagnosis of colorectal cancer, - History of metabolic syndrome, cardiovascular disease, hepatic disease, chronic kidney disease, major hormonal or hematological disease, pulmonary disease,
- With a history of autoimmune disease, with a history of inflammatory diseases (pancreatitis, chron's, ulcerative colitis, etc.),
- Those who use nonsteroidal anti-inflammatory drugs (NSAIDs),
- Alcoholic and other drug addicts,
- Smokers,
- Those with mental disorders (major depressive disorder, dementia),
- Those who take corticosteroid or hormone therapy,
- Those who have an existing infectious disease, those who receive medical nutrition therapy for any disease
- For healthy group
- Individuals aged 18 and under and 65 years and older,
- History of metabolic syndrome, cardiovascular disease, hepatic disease, chronic kidney disease, major hormonal or hematological disease, pulmonary disease,
- With a history of autoimmune disease, with a history of inflammatory diseases (pancreatitis, chron's, ulcerative colitis, etc.),
- Those who use nonsteroidal anti-inflammatory drugs (NSAIDs),
- Pregnant and lactating women,
- Alcoholic and other drug addicts,
- Smokers, those with mental disorders (major depressive disorder, dementia),
- Those taking corticosteroid or hormone therapy,
- Those with existing infectious disease,
- Those receiving medical nutrition therapy for any illness
Key Trial Info
Start Date :
October 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2025
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT06018077
Start Date
October 15 2022
End Date
August 31 2025
Last Update
August 30 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hacettepe University Health Science Faculty, Nutrition and Dietetic Department
Ankara, Turkey (Türkiye), 06280
2
Ankara Bilkent City Hospital, Oncology Hospital, Medical Oncology Outpatient Clinic
Ankara, Turkey (Türkiye), 06800